Soc. Generale Discount Zert FRE 3.../ DE000SV7Q5M1 /
16.12.2024 8:18:51 | Изменение- | Бид22:00:38 | Предложение22:00:38 | Базовый актив | Цена исполнения | Дата истечения | Тип опциона |
---|---|---|---|---|---|---|---|
21.98EUR | - | - Величина цены спроса: - |
- Величина цены предложения: - |
FRESENIUS SE+CO.KGAA... | - - | 31.12.2024 | Call |
GlobeNewswire
24.04
Travere Therapeutics and CSL Vifor Announce European Commission Approves FILSPARI® (sparsentan) for ...
GlobeNewswire
23.04
Transferring Biomedical Research to Patients Faster: ForTra gGmbH Announces Positive Funding Track R...
GlobeNewswire
23.02
Travere Therapeutics and CSL Vifor Announce Sparsentan Receives Positive CHMP Opinion for the Treatm...
GlobeNewswire
04.09.2023
CIO Leadership: Generative AI and Visionary Leadership in the Enterprise Will Power the Discussion a...
GlobeNewswire
31.08.2023
CytoSorbents Granted Expanded ANVISA Registration to Treat Shock with CytoSorb in Brazil
- Первая страница
- Назад
- 1
- 2
- 3
- 4
- Следующий
- Последняя страница